Position in JNJ
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,031,092,550
+$1,459,969,344 QoQ
Shares Held
16,491,133
+32.7% QoQ
Ownership
0.685%
of shares outstanding
% of Portfolio
0.49%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 95.86985321141974.ToString("F0")%
Shared 0.ToString("F0")%
None 4.130146788580263.ToString("F0")%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $32,740,779,918 across 15 Drug Manufacturers - General names. JNJ ranks #2 (12.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
13,992,224 | $12,869,627,867 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
16,491,133 | $4,031,092,550 | |
| 3 | AZN |
Astrazeneca PLC
|
19,489,220 | $3,843,663,968 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
26,248,108 | $3,658,198,811 | |
| 5 | ABBV |
AbbVie Inc.
|
13,003,989 | $2,828,237,567 | |
| 6 | MRK |
Merck & Co., Inc.
|
23,042,842 | $2,771,823,463 | |
| 7 | AMGN |
Amgen Inc
|
1,867,189 | $656,970,449 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
10,250,238 | $621,676,934 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,031,092,550 | 16,491,133 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,571,123,206 | 12,423,886 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,625,787,034 | 8,768,132 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,279,668,165 | 8,377,533 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,675,991,145 | 10,106,073 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,354,872,189 | 16,283,171 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $4,077,502,850 | 25,160,452 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,640,727,940 | 24,909,195 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $3,453,977,249 | 21,834,359 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,930,232,356 | 18,694,860 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $2,875,475,500 | 18,462,122 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,620,579,352 | 27,915,535 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,159,239,155 | 26,833,801 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $5,171,918,776 | 29,277,774 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $4,154,020,343 | 25,428,626 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,370,792,340 | 24,622,795 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,670,497,988 | 20,710,365 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,479,552,046 | 14,494,371 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,451,165,765 | 15,177,497 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,497,567,293 | 15,160,661 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $2,524,752,588 | 15,362,048 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,712,743,951 | 17,236,904 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,463,165,556 | 16,544,637 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $2,402,873,088 | 17,086,490 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $2,491,634,305 | 19,001,253 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||